522 related articles for article (PubMed ID: 35242319)
1. Extraintestinal manifestation of inflammatory bowel disease and associated factors in pediatric patients.
Rahmani P; Rasti G; Gorgi M; Motamed F; Sharifi P
Ann Med Surg (Lond); 2022 Mar; 75():103363. PubMed ID: 35242319
[TBL] [Abstract][Full Text] [Related]
2. Extraintestinal Manifestations in Children Diagnosed with Inflammatory Bowel Disease.
Kavcar Z; Civan HA; Taskin DG; Hatipoglu SS
Sisli Etfal Hastan Tip Bul; 2023; 57(1):73-78. PubMed ID: 37064841
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory bowel disease in children--clinical, endoscopic, radiologic and histopathologic investigation.
Seo JK; Yeon KM; Chi JG
J Korean Med Sci; 1992 Sep; 7(3):221-35. PubMed ID: 1285921
[TBL] [Abstract][Full Text] [Related]
4. Clinical presentation of Crohn's, ulcerative colitis, and indeterminate colitis: Symptoms, extraintestinal manifestations, and disease phenotypes.
Yu YR; Rodriguez JR
Semin Pediatr Surg; 2017 Dec; 26(6):349-355. PubMed ID: 29126502
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary Manifestations in Adolescents With Inflammatory Bowel Disease.
Barfield E; Deshmukh F; Slighton E; Lentine J; Lu Y; Ma X; Christos PJ; Sockolow RE; Loughlin G; Pillai S
Clin Pediatr (Phila); 2020 Jun; 59(6):573-579. PubMed ID: 32146830
[No Abstract] [Full Text] [Related]
6. THE ONSET OF CLINICAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASE PATIENTS.
Nóbrega VG; Silva INN; Brito BS; Silva J; Silva MCMD; Santana GO
Arq Gastroenterol; 2018; 55(3):290-295. PubMed ID: 30540094
[TBL] [Abstract][Full Text] [Related]
7. Role of fecal calprotectin testing to predict relapse in teenagers with inflammatory bowel disease who report full disease control.
van Rheenen PF
Inflamm Bowel Dis; 2012 Nov; 18(11):2018-25. PubMed ID: 22275341
[TBL] [Abstract][Full Text] [Related]
8. Isolated Crohn's Colitis: Is Localization Crucial? Characteristics of Pediatric Patients From the CEDATA-GPGE Registry.
Elonen L; Wölfle L; de Laffolie J; Posovszky C;
Front Pediatr; 2022; 10():875938. PubMed ID: 35712614
[TBL] [Abstract][Full Text] [Related]
9. Impact of obesity on disease activity and disease outcome in inflammatory bowel disease: Results from the Swiss inflammatory bowel disease cohort.
Greuter T; Porchet F; Braga-Neto MB; Rossel JB; Biedermann L; Schreiner P; Scharl M; Schoepfer AM; Safroneeva E; Straumann A; Rogler G; Vavricka SR
United European Gastroenterol J; 2020 Dec; 8(10):1196-1207. PubMed ID: 33276710
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of irritable bowel syndrome-type symptoms in paediatric inflammatory bowel disease, and the relationship with biochemical markers of disease activity.
Diederen K; Hoekman DR; Hummel TZ; de Meij TG; Koot BG; Tabbers MM; Vlieger AM; Kindermann A; Benninga MA
Aliment Pharmacol Ther; 2016 Jul; 44(2):181-8. PubMed ID: 27110920
[TBL] [Abstract][Full Text] [Related]
11. Identification of a prodromal period in Crohn's disease but not ulcerative colitis.
Pimentel M; Chang M; Chow EJ; Tabibzadeh S; Kirit-Kiriak V; Targan SR; Lin HC
Am J Gastroenterol; 2000 Dec; 95(12):3458-62. PubMed ID: 11151877
[TBL] [Abstract][Full Text] [Related]
12. INTERACTIONS AMONG INTERLEUKIN-6, C-REACTIVE PROTEIN AND INTERLEUKIN-6 (-174) G/C POLYMORPHISM IN THE PATHOGENESIS OF CROHN'S DISEASE AND ULCERATIVE COLITIS.
Takač B; Mihaljević S; Glavaš-Obrovac L; Kibel A; Suver-Stević M; Canecki-Varžić S; Samardžija M; Rajkovac I; Kovač D; Štefanić M
Acta Clin Croat; 2020 Mar; 59(1):67-80. PubMed ID: 32724277
[TBL] [Abstract][Full Text] [Related]
13. Disordered eating behaviors in pediatric patients with inflammatory bowel disease in remission or mild-moderate disease activity.
Vickers M; Whitworth J; Alvarez LM; Bowden M
Nutr Clin Pract; 2024 Aug; 39(4):881-887. PubMed ID: 38326229
[TBL] [Abstract][Full Text] [Related]
14. [Extraintestinal manifestations of inflammatory bowel disease].
Rogler G; Schölmerich J
Med Klin (Munich); 2004 Mar; 99(3):123-30. PubMed ID: 15024484
[TBL] [Abstract][Full Text] [Related]
15. Multi-item Measures for Paediatric Inflammatory Bowel Diseases: The ABCs of All Those Acronyms.
Ledder O; Turner D
J Crohns Colitis; 2023 Jul; 17(7):1154-1168. PubMed ID: 36734262
[TBL] [Abstract][Full Text] [Related]
16. Relationship of clinical symptoms with biomarkers of inflammation in pediatric inflammatory bowel disease.
Hoekman DR; Diederen K; Koot BG; Tabbers MM; Kindermann A; Benninga MA
Eur J Pediatr; 2016 Oct; 175(10):1335-42. PubMed ID: 27573259
[TBL] [Abstract][Full Text] [Related]
17. The association of infliximab trough levels with disease activity in pediatric inflammatory bowel disease.
Hoekman DR; Brandse JF; de Meij TG; Hummel TZ; Löwenberg M; Benninga MA; D'Haens GR; Kindermann A
Scand J Gastroenterol; 2015; 50(9):1110-7. PubMed ID: 25865965
[TBL] [Abstract][Full Text] [Related]
18. Cholelithiasis in inflammatory bowel disease. A case-control study.
Lorusso D; Leo S; Mossa A; Misciagna G; Guerra V
Dis Colon Rectum; 1990 Sep; 33(9):791-4. PubMed ID: 2202567
[TBL] [Abstract][Full Text] [Related]
19. Severe Disease Activity Based on the Paris Classification Is Associated with the Development of Extraintestinal Manifestations in Korean Children and Adolescents with Ulcerative Colitis.
Jang HJ; Suh HR; Choi S; Hong SJ; Cho SM; Choi KH; Choe BH; Kang B;
J Korean Med Sci; 2021 Nov; 36(44):e278. PubMed ID: 34783212
[TBL] [Abstract][Full Text] [Related]
20. HLA-DRB1 alleles may influence disease phenotype in patients with inflammatory bowel disease: a critical reappraisal with review of the literature.
Annese V; Piepoli A; Latiano A; Lombardi G; Napolitano G; Caruso N; Cocchiara E; Accadia L; Perri F; Andriulli A
Dis Colon Rectum; 2005 Jan; 48(1):57-64; discussion 64-5. PubMed ID: 15690658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
